On September 29, California Governor Arnold Schwarzenegger signed into law a bill (S.B. 1765) that requires pharmaceutical companies that do business in California to adhere to the OIG guidance and PhRMA Code. Among the requirements is that pharma companies doing business in California develop a compliance program and detail the amount of promotional money they'll spend on physicians annually. The deadline: July 1, 2005. Did Cephalon cross the off-label line in promoting its narcolepsy ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Updates on the Pharma Front, you'll get exclusive access to a large archive of premium content.

Already registered? here.